Axsome Therapeutics (AXSM) EV/EBITDA US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EV/EBITDA ? -29.2 -11.2 -18.0 -17.4 -15.2   -9.87  
Changes by years, y/y, % -41% -62% +60% -3% -13%     +48.4%

Axsome Therapeutics. EV/EBITDA

Created with Highcharts 6.0.6-0.9-0.9-0.7-0.7-9.1-9.1-3.8-3.8-3.8-3.8-2.1-2.1-49.3-49.3-29.2-29.2-11.2-11.2-18.0-18.0-17.4-17.4-15.2-15.2-9.9-9.9201320142015201620172018201920202021202220222023LTM-60-50-40-30-20-100smart-lab.ru

Axsome Therapeutics. EV/EBITDA, changes, %

Created with Highcharts 6.0.6-28.0-28.01233.01233.0-58.3-58.3-0.9-0.9-43.8-43.82241.82241.8-40.7-40.7-61.7-61.760.360.3-3.2-3.2-12.7-12.7-35.0-35.020142015201620172018201920202021202220222023LTM-50005001000150020002500smart-lab.ru

Axsome Therapeutics (AXSM) EV/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EV/EBITDA ? -17.4 -16.3 -13.0 -12.3 -13.9   -9.87
Changes by years, y/y, % +50% -14% -31% -33% -20%    
Changes by quarters, q/q, % -6% -6% -20% -5% +13%    

Axsome Therapeutics. EV/EBITDA

Created with Highcharts 6.0.6-2.4-2.4-0.9-0.91.51.5-17.8-17.8-13.8-13.8-7.9-7.9-5.6-5.6-3.8-3.8-1.4-1.4-3.5-3.5-4.0-4.0-4.1-4.1-1.7-1.7-2.6-2.6-2.8-2.8-2.4-2.4-12.5-12.5-20.2-20.2-12.9-12.9-50.6-50.6-22.5-22.5-30.8-30.8-26.1-26.1-29.4-29.4-21.3-21.3-22.9-22.9-9.9-9.9-11.3-11.3-11.6-11.6-0.1-0.1-10.7-10.7-11.6-11.6-19.3-19.3-19.0-19.0-18.7-18.7-18.4-18.4-17.4-17.4-16.3-16.3-13.0-13.0-12.3-12.3-13.9-13.92014Q42015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-60-50-40-30-20-10010smart-lab.ru

Axsome Therapeutics. EV/EBITDA, changes, y/y, %

Created with Highcharts 6.0.6640.1640.1774.1774.1-466.9-466.9-78.8-78.8-89.7-89.7-55.3-55.3-29.5-29.59.59.519.919.9-27.8-27.8-29.0-29.0-42.9-42.9631.1631.1692.2692.2358.8358.82035.12035.180.180.152.352.3102.2102.2-41.9-41.9-5.2-5.2-25.8-25.8-62.1-62.1-61.7-61.7-45.6-45.6-99.4-99.4-53.3-53.316.716.771.271.268.768.761.861.872.672.650.250.2-14.3-14.3-30.6-30.6-33.1-33.1-19.6-19.62015Q42016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-1000-50005001000150020002500smart-lab.ru

Axsome Therapeutics. EV/EBITDA, changes, q/q, %

Created with Highcharts 6.0.6-62.4-62.4-269.3-269.3-1261.6-1261.6-22.7-22.7-42.5-42.5-28.9-28.9-32.8-32.8-62.4-62.4148.7148.712.112.14.54.5-58.8-58.849.849.810.210.2-15.9-15.9426.5426.562.362.3-36.2-36.2291.3291.3-55.6-55.637.237.2-15.2-15.212.412.4-27.5-27.57.47.4-56.7-56.713.613.63.03.0-98.8-98.87299.37299.38.28.266.766.7-1.4-1.4-1.2-1.2-1.7-1.7-5.8-5.8-6.3-6.3-20.0-20.0-5.2-5.213.013.02015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-2k02k4k6k8ksmart-lab.ru